Outcomes from a Phase II medical trial of 24 sufferers who been given this combination (which include sixteen who experienced failed on single-agent sorafenib, 6 who had failed on sunitinib,…
Outcomes from a Phase II medical trial of 24 sufferers who been given this combination (which include sixteen who experienced failed on single-agent sorafenib, 6 who had failed on sunitinib,…
X Biol. Creator manuscript; accessible in PMC 2018 April 25.Creator Manuscript Writer Manuscript Creator Manuscript Writer ManuscriptShevde and SamantPagesupporting OPN being a dual marker of bone destruction and angiogenic action…